Prehypertension in disease-free adults: A marker for an adverse cardiometabolic risk profile

Hypertension Research

Volumn 33, Issue 9, 2010, Pages 905-910

  Gupta, Alok K ^a   McGlone, Meghan ^a   Greenway, Frank L ^a   Johnson, William D ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

BMI; CRP; insulin resistance; metabolic syndrome; waist circumference

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HOMEOSTASIS; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREHYPERTENSION; PREVALENCE; PREVENTIVE HEALTH SERVICE; PROTEIN BLOOD LEVEL; PULSE PRESSURE; RISK REDUCTION; SEX RATIO; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; MALE; MIDDLE AGED; NUTRITION SURVEYS; PREHYPERTENSION; PREVALENCE; RISK FACTORS; SEX FACTORS; TRIGLYCERIDES; UNITED STATES; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 77956411423     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2010.91     Document Type: Article

References (34)

1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta- analysis of individual data for one million adults in 61 prospective studies. [Published erratum appears in Lancet 2003; 361:1060]. Lancet 2002; 360: 1903-1913.
2. Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, Qizilbash N, Collins R, Peto R. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Prospective Studies Collaboration. Lancet 2009; 373: 1083-1096.
3. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples LA, D'Agostino Sr RB, O'Donnell CJ. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116: 39-48. (Pubitemid 47016245)
4. St-Pierre J, Lemieux I, Perron P, Brisson D, Santure M, Vohl MC, Despres JP, Gaudet D. Relation of the 'hypertriglyceridemic waist' phenotype to earlier manifestations of coronary artery disease in patients with glucose intolerance and type 2 diabetes mellitus. Am J Cardiol 2007; 99: 369-373.
5. Haffner SM. Abdominal adiposity and cardiometabolic risk: do we have all the answers? Am J Med 2007; 120 (9 Suppl 1): S10-S16; discussion S16-S17. Review.
6. Patsch JR, Miesenbock G, Hopferwieser T, Muhlberger V, Knapp E, Dunn JK, Gotto Jr AM, Patsch W. Relation of triglyceride metabolism and coronary artery disease: studies in the postprandial state. Arterioscler Thromb 1992; 12: 1336-1345.
7. Castelli WP, Doyle JT, Gordon T, Hames CG, Hjortland MC, Hulley SB, Kagan A, Zukel WJ. HDL cholesterol and other lipids in coronary heart disease. Circulation 1977; 55: 767-772.
8. Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Manttari M, Heinonen OP, Frick MH. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki heart study: implications for treatment. Circulation 1992; 85: 37-45.
9. Nielson C, Lange T, Hadjokas N. Blood glucose and coronary artery disease in nondiabetic patients. Diabetes Care 2006; 29: 998-1001.
10. Gupta AK, Greenway FL, Cornelissen G, Pan W, Halberg F. Prediabetes is associated with abnormal circadian blood pressure variability. J Hum Hypertens 2008; 22: 627-633.
11. Reaven G. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. Endocrinol Metab Clin North Am 2004; 33: 283-303. (Pubitemid 38680631)
12. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
13. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
14. The IDF consensus worldwide definition of the metabolic syndrome. Part 1: Worldwide definition for use in clinical practice. http://www.idf.org. Accessed 28 July 2005.
15. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzi Jr JL, Jones DW, Materson BJ, Oparil S, Wright Jr JT, Rocella EJ, the National High Blood Pressure Education Program Committee. The seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure. The JNC 7 Report. JAMA 2003; 289: 2560-2572.
16. Reaven GM. The metabolic syndrome: is this diagnosis necessary?. [Published erratum appears in Am J Clin Nutr 2006; 84:1253]. Am J Clin Nutr 2006; 83: 1237-1247.
17. Analytic and Reporting Guidelines: the National Health and Nutrition Examination Survey, NHANES 2005-2006. National Center for Health Statistics, Centers for Disease Control and Prevention: Hyattsville, MD, 2006.
18. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Questionnaire (or Examination Protocol, or Laboratory Protocol). U.S. Department of Health and Human Services, Centers for Disease Control and Prevention: Hyattsville, MD, 1999-2006. http://www.cdc.gov/nchs/nhanes.htm.
19. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913.
20. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001; 358: 1682-1686.
21. De Marco M, de Simone G, Roman MJ, Chinali M, Lee ET, Russell M, Howard BV, Devereux RB. Cardiovascular and metabolic predictors of progression of prehyperten- sion into hypertension. The Strong Heart Study. Hypertension 2009; 54: 974-980.
22. Mainous AG, Everett CJ, Liszka HA, King DE, Egan BM. Prehypertension and mortality in a nationally representative cohort. Am J Cardiology 2004; 94: 1496-1500.
23. Gu Q, Burt VL, Paulose-Ram R, Yoon S, Gillum RF. High blood pressure and cardiovascular disease mortality risk among U.S. adults: the third National Health and Nutrition Examination Survey mortality follow-up study. Ann Epidemiol 2008; 18: 515.
24. Ferguson TS, Younger NO, Tulloch-Reid MK, Wright MB, Ward EM, Ashley DE, Wilks RJ. Prevalence of prehypertension and its relationship to risk factors for cardiovascular disease in Jamaica: analysis from a cross-sectional survey. BMC Cardiovasc Disord 2008; 8: 20.
25. Ishikawa Y, Ishikawa J, Ishikawa S, Kayaba K, Nakamura Y, Shimada K, Kajii E, Pickering TG, Kario K, Jichi Medical School Cohort Investigators Group. Prevalence and determinants of prehypertension in a Japanese general population: the Jichi Medical School Cohort Study. Hypertens Res 2008; 31: 1323-1330.
26. Onat A, Yazici M, Can G, Kaya Z, Bulur S, Hergenc G. Predictive value of prehypertension for metabolic syndrome, diabetes, and coronary heart disease among Turks. Am J Hypertens 2008; 21: 890-895.
27. Gu D, Chen J, Wu X, Duan X, Jones DW, Huang JF, Chen CS, Chen JC, Kelly TN, Whelton PK, He J. Prehypertension and risk of cardiovascular disease in Chinese adults. J Hypertens 2009; 27: 721-729.
28. Hozawa A, Kuriyama S, Kakizaki M, Ohmori-Matsuda K, Ohkubo T, Tsuji I. Attributable risk fraction of prehypertension on cardiovascular disease mortality in the Japanese population: the Ohsaki Study. Am J Hypertens 2009; 22: 267-272.
29. Ganguly SS, Al-Shafaee MA, Bhargava K, Duttagupta KK. Prevalence of prehyperten- sion and associated cardiovascular risk profiles among prediabetic Omani adults. BMC Public Health 2008; 8: 108.
30. Gupta AK, Cornelissen G, Greenway FL, Halberg F, Johnson WD. Increased cardiovascular disease risk in obese: association of altered metabolic profile with abnormal circadian blood pressure variability, and endothelial dysfunction. JASH 2010 (in review).
31. Halberg F, Cornelissen G, Katinas G, Tvildiani L, Gigolashvili M, Janashia K, Toba T, Revilla M, Regal P, Sothern RB, Wendt HW, Wang ZR, Zeman M, Jozsa R, Singh RB, MitsutakeG, ChibisovSM, Lee J, Holley D, Holte JE, Sonkowsky RP, Schwartzkopff O, Delmore P, Otsuka K, Bakken EE, Czaplicki J, International BIOCOS Group. Chron- obiology's progress: season's appreciations 2004-2005. Time, frequency, phase, variable, individual, age- and site-specific chronomics. J Appl Biomed 2006; 4: 1-38.
32. Halberg F, Cornelissen G, Katinas G, Tvildiani L, Gigolashvili M, Janashia K, Toba T, Revilla M, Regal P, Sothern RB, Wendt HW, Wang ZR, Zeman M, Jozsa R, Singh RB, MitsutakeG, ChibisovSM, Lee J, Holley D, Holte JE, Sonkowsky RP, Schwartzkopff O, Delmore P, Otsuka K, Bakken EE, Czaplicki J, International BIOCOS Group. Chron- obiology's progress: part II, chronomics for an immediately applicable biomedicine. J Appl Biomed 2006; 4: 73-86.
33. Corrado E, Rizzo M, Coppola G, Muratori I, Carella M, Novo S. Endothelial dysfunction and carotid lesions are strong predictors of clinical events in patients with early stages of atherosclerosis: a 24-month follow-up study. Coron Artery Dis 2008; 19: 139-144.
34. Yu D, Huang J, Hu D, Chen J, Cao J, Li J, Gu D. Association between prehypertension and clustering of cardiovascular disease risk factors among Chinese adults. J Cardiovasc Pharmacol 2009; 53: 388-400.